PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30262795-2	2018	While widespread literature is concentrated on casein or whey protein for production of ACE-inhibitory peptides, relatively little information is available on selecting the proper proteases to hydrolyze the protein.	Peptides	103-111	angiotensin I converting enzyme	Bos taurus	88-91	
35499015-4	2022	In silico molecular docking studies predicted 20 antihypertensive peptides, exhibiting non-bond interactions between hard chhurpi peptides and ACE catalytic residues.	Peptides	130-138	angiotensin I converting enzyme	Bos taurus	143-146	
30599943-6	2019	Pepsite2 predicted that these peptides would largely bind via Gln281, His353, Lys511, His513, Tyr520 and Tyr523 of ACE to inhibit the enzyme, while Trp629 would be the predominant binding site of peptides in reducing DPP-IV activity.	Peptides	30-38	angiotensin I converting enzyme	Bos taurus	115-118	
19389946-0	2009	Short communication: bovine kappa-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides.	Peptides	119-127	angiotensin I converting enzyme	Bos taurus	70-101	
19389946-0	2009	Short communication: bovine kappa-casein variants result in different angiotensin I converting enzyme (ACE) inhibitory peptides.	Peptides	119-127	angiotensin I converting enzyme	Bos taurus	103-106	
12417344-0	2002	Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein.	Peptides	43-51	angiotensin I converting enzyme	Bos taurus	0-31	
25020248-0	2014	Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis.	Peptides	95-103	angiotensin I converting enzyme	Bos taurus	52-83